Picture of Mural Oncology logo

MURA Mural Oncology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

REG-Parkwood Master Fund Ltd: Form 8.3 - Mural Oncology Plc

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH
TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN
RELEVANT SECURITIES REPRESENTING 1% OR MORE

TORONTO, April 24, 2025 --

1.             KEY INFORMATION

 (a)  Full name of discloser                                                                            Parkwood Master Fund Ltd.  
 (b)  Owner or controller of interests and short                                                                                   
  positions disclosed, if different from 1(a)                                                                                      
  The naming of nominee or vehicle companies                                                                                       
  is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.                                           
 (c)  Name of offeror/offeree in relation to whose                                                      Mural Oncology Plc.        
  relevant securities this form relates  Use a separate form for each offeror/offeree                                              
 (d)  If an exempt fund manager connected with                                                                                     
  an offeror/offeree, state this and specify                                                                                       
  identity of offeror/offeree (Note 1)                                                                                             
 (e)  Date position held/dealing undertaken  For an opening position disclosure, state the              April 21, 2025             
  latest practicable date prior to the disclosure                                                                                  
 (f)  In addition to the company in 1(c) above, is                                                      NO                         
  the discloser also making disclosures in                                                                                         
  respect of any other party to the offer?  If it is a cash offer or possible cash offer, state "N/A"                              

2.             INTERESTS AND SHORT POSITIONS

If there are interests and short positions to disclose in more than one class
of relevant securities of the offeror or offeree named in 1(c), copy table 2
for each additional class of relevant security.

Interests and short positions in the relevant securities of the offeror or
offeree to which the disclosure relates following the dealing (if any)

 Class of relevant security                                                               
  (Note 3)                                                                                
                                                      Interests       Short positions     
                                                      Number   %      Number    %         
 (1)  Relevant securities owned and/or controlled     494,120  2.9                        
 (2)  Cash-settled derivatives                                                            
 (3)  Stock-settled derivatives (including options)                                       
  and agreements to purchase/ sell                                                        
 Total                                                494,120  2.9                        

All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any
open stock-settled derivative positions (including traded options), or
agreements to purchase or sell relevant securities, should be given on a
Supplemental Form 8.

3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE
DISCLOSURE (Note 4)

Where there have been dealings in more than one class of relevant securities
of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)           Purchases and sales

 Class of relevant   Purchase/sale  Number of     Price per unit   
  security                           securities    (Note 5)        
 IE000LK2BOB4        Purchase       263,551       $2.4646          
 IE000LK2BOB4        Purchase       155,569       $2.4103          
 IE000LK2BOB4        Purchase       75,000        $2.6278          

(b)           Cash-settled derivative transactions

 Class of     Product         Nature of dealing                                 Number of      Price        
  relevant     description     e.g. opening/ closing a long/ short position,     reference      per unit    
  security     e.g. CFD        increasing/ reducing a long/ short position       securities     (Note 5)    
                                                                                 (Note 6)                   
                                                                                                            

(c)           Stock-settled derivative transactions (including
options)

(i)            Writing, selling, purchasing or varying

 Class of     Product         Writing, purchasing, selling,   Number         Exercise      Type          Expiry   Option               
  relevant     description     varying                         of             price per     e.g.          date     money               
  security     e.g. call       etc.                            securities     unit          American,              paid/               
               option                                          to which                     European               received per unit   
                                                               option                       etc.                                       
                                                               relates                                                                 
                                                               (Note 6)                                                                
                                                                                                                                       

(ii)           Exercise

 Class of     Product         Exercising/   Number of     Exercise      
  relevant     description     exercised     securities    price per    
  security     e.g. call       against                     unit         
               option                                      (Note 5)     
                                                                        

(d)           Other dealings (including transactions in respect of
new securities) (Note 3)

 Class of     Nature of dealing       Details  Price per unit (if   
  relevant     e.g. subscription,               applicable)         
  security     conversion, exercise             (Note 5)            
                                                                    

4.             OTHER INFORMATION

(a)           Indemnity and other dealing arrangements

 Details of any indemnity or option arrangement, or any agreement                                                                      
  or understanding, formal or informal, relating to relevant securities                                                                
  which may be an inducement to deal or refrain from dealing entered                                                                   
  into by the person making the disclosure and any party to the offer or                                                               
  any person acting in concert with a party to the offer.  Irrevocable commitments and letters of intent should not be included. If    
  there are no such agreements, arrangements or understandings, state "none"                                                           
 None                                                                                                                                  

(b)           Agreements, arrangements or understandings relating to
options or derivatives

 Full details of any agreement, arrangement or understanding                 
  between the person disclosing and any other person relating to the         
  voting rights of any relevant securities under any option referred to      
  on this form or relating to the voting rights or future acquisition or     
  disposal of any relevant securities to which any derivative referred to    
  on this form is referenced. If none, this should be stated.                
 None                                                                        

(c)           Attachments

 Is a Supplemental Form 8 attached?  NO  

 Date of disclosure  April 22, 2025  
 Contact name        Dan Sternberg   
 Telephone number    1 416 363 9049  

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory
Information Service.

 

 



Copyright (c) 2025 PR Newswire Association,LLC. All Rights Reserved

Recent news on Mural Oncology

See all news